Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Evogene (EVGN) Equity Ratio (2016 - 2024)

Historic Equity Ratio for Evogene (EVGN) over the last 9 years, with Q4 2024 value amounting to 0.04.

  • Evogene's Equity Ratio fell 11543.19% to 0.04 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.04, marking a year-over-year decrease of 11543.19%. This contributed to the annual value of 0.04 for FY2024, which is 11543.19% down from last year.
  • According to the latest figures from Q4 2024, Evogene's Equity Ratio is 0.04, which was down 11543.19% from 0.07 recorded in Q2 2024.
  • Over the past 5 years, Evogene's Equity Ratio peaked at 0.76 during Q2 2021, and registered a low of 0.04 during Q4 2024.
  • Its 5-year average for Equity Ratio is 0.4, with a median of 0.38 in 2022.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 36661.33% in 2021, then crashed by 11543.19% in 2024.
  • Quarter analysis of 5 years shows Evogene's Equity Ratio stood at 0.15 in 2020, then surged by 366.61% to 0.7 in 2021, then dropped by 29.23% to 0.5 in 2022, then plummeted by 52.6% to 0.24 in 2023, then crashed by 115.43% to 0.04 in 2024.
  • Its last three reported values are 0.04 in Q4 2024, 0.07 for Q2 2024, and 0.24 during Q4 2023.